These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7458 related articles for article (PubMed ID: 1371433)

  • 41. Effect of fixation on interphase cytogenetic analysis by direct fluorescence in situ hybridization on cell imprints.
    Kapranos N; Kontogeorgos G; Frangia K; Kokka E
    Biotech Histochem; 1997 May; 72(3):148-51. PubMed ID: 9187738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitumour activity of a melanoma-specific immunotoxin, ME20-LysPE40.
    Wolff EA; Hellström I; Chace DF; Hellström KE; Siegall CB
    Ther Immunol; 1995 Jun; 2(3):137-45. PubMed ID: 8885132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA expression and tumor-infiltrating immune cells in uveal melanoma.
    de Waard-Siebinga I; Hilders CG; Hansen BE; van Delft JL; Jager MJ
    Graefes Arch Clin Exp Ophthalmol; 1996 Jan; 234(1):34-42. PubMed ID: 8750848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Computer database for melanoma: a clinical management and research tool to ensure continuous quality assessment.
    Reintgen D; Cruse CW; Schroer K; Glass F; Saba H; Puleo C; King J; Berman C; Hannon L; Cox C
    Semin Surg Oncol; 1993; 9(3):208-14. PubMed ID: 8516605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stable and strong expression of basic fibroblast growth factor in naevus cell naevus contrasts with aberrant expression in melanoma.
    Ueda M; Funasaka Y; Ichihashi M; Mishima Y
    Br J Dermatol; 1994 Mar; 130(3):320-4. PubMed ID: 8148272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of misdiagnosis and delay in diagnosis on clinical outcome in melanomas of the foot.
    Bennett DR; Wasson D; MacArthur JD; McMillen MA
    J Am Coll Surg; 1994 Sep; 179(3):279-84. PubMed ID: 8069422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The clinical experience with interleukin-2 in cancer therapy.
    Dillman RO
    Cancer Biother; 1994; 9(3):183-209. PubMed ID: 7820182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between malignancy level of AKR lymphoma variants and sensitivity to hyperthermia.
    Leibovici J; Klorin G; Klein O; Michowitz M
    Cancer Biother; 1995; 10(1):53-60. PubMed ID: 7780488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Binding of vitamin E in mammalian tumor cells in culture.
    Prasad KN; Gaudreau D; Brown J
    Proc Soc Exp Biol Med; 1981 Feb; 166(2):167-74. PubMed ID: 7208478
    [No Abstract]   [Full Text] [Related]  

  • 50. [Carcinostatic action of synthetic polymers on transplantable tumors].
    Korosteleva TA; Movsesian KA; Meiia NV; Nesterova VI; Sorokin AIa
    Vopr Onkol; 1982; 28(6):39-41. PubMed ID: 7090295
    [No Abstract]   [Full Text] [Related]  

  • 51. Measurement of the rate of death of dog tumour cells transplanted into athymic "nude" mice.
    Holmes JM
    J Comp Pathol; 1981 Oct; 91(4):511-9. PubMed ID: 6947997
    [No Abstract]   [Full Text] [Related]  

  • 52. Inhibition of tyrosinase activity by 4-tert-butylcatechol and other depigmenting agents.
    Usami Y; Landau AB; Fukuyama K; Gellin GA
    J Toxicol Environ Health; 1980 May; 6(3):559-67. PubMed ID: 6775084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of laser irradiation on transplantable melanoma].
    Deviatkov ND; Pletnev SD; Gorodilova VV; Papliian NP; Gol'bert ZV
    Vopr Onkol; 1970; 16(9):59-64. PubMed ID: 5495104
    [No Abstract]   [Full Text] [Related]  

  • 54. Working session report: in vivo-in vitro screening.
    Venditti JM
    Cancer Chemother Rep 3; 1972 May; 3(1):57-62. PubMed ID: 5049711
    [No Abstract]   [Full Text] [Related]  

  • 55. The incidence of malignant melanoma (0 to 15 years of age) arising in "large" congenital nevocellular nevi.
    Quaba AA; Wallace AF
    Plast Reconstr Surg; 1986 Aug; 78(2):174-81. PubMed ID: 3725963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. UVA-induced melanocytic lesions.
    Jones SK; Moseley H; Mackie RM
    Br J Dermatol; 1987 Jul; 117(1):111-5. PubMed ID: 3651330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiation antigens of melanoma and melanocytes.
    Houghton AN; Cordon-Cardo C; Eisinger M
    Int Rev Exp Pathol; 1986; 28():217-48. PubMed ID: 3516910
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of cyclophosphamide on the immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in rats.
    Harkonen S; Mischak R; Lopez H; Stoudemire J
    Cancer Drug Deliv; 1987; 4(3):151-7. PubMed ID: 3502453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Steroids and neuroendocrine hormones detected by the immunoperoxidase technique from malignant melanomas and nevi of the choroid and conjunctiva.
    Di Tondo U; Balestrazzi E; Santeusanio G; Pintucci S; Spadea L
    Ophthalmologica; 1986; 192(1):34-8. PubMed ID: 3010209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphoscintigraphy as a guide to treatment in malignant melanoma.
    Woods JE; Freedman AM; Brown ML
    Ann Plast Surg; 1989 Feb; 22(2):150-5. PubMed ID: 2735710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 373.